2022. THE VALUE OF ANTI-VEGF DRUGS IN THE TREATMENT OF VARIOUS STAGES OF DIABETIC RETINOPATHY (LITERATURE REVIEW). World Bulletin of Public Health. 10, (May 2022), 81–84.